Skip to content

Phone-alt Phone-alt Envelope Map-marker-alt Map-marker-alt

Search

Close

Home
About us
- Investment strategy
- Investment focus
Investments
- rancoderm GmbH
Investor Relations
News
- Corporate News
- ad-hoc notification
Contact

Menu

Home
About us
- Investment strategy
- Investment focus
Investments
- rancoderm GmbH
Investor Relations
News
- Corporate News
- ad-hoc notification
Contact

2023 – 2025

Contact

Board of Directors: Dr Bruno Rosen
Andreas Danner
Ziegelhäuser Landstraße 3
69120 Heidelberg
Germany

T. +49 6221 64924 88
kontakt(@)bioxxmed.ag

About us

Investment strategy
Investment focus

Menu

Investment strategy
Investment focus

Investments

rancoderm GmbH

Menu

rancoderm GmbH

Investor Relations

Shares
Annual Reports
Annual Accounts
Annual Shareholders’ Meeting
Directors' Dealings
Management
Investors’ Relations Contact
Reports
Kapitalerhöhung 2024

Menu

Shares
Annual Reports
Annual Accounts
Annual Shareholders’ Meeting
Directors' Dealings
Management
Investors’ Relations Contact
Reports
Kapitalerhöhung 2024

News

Corporate News
ad-hoc notification

Menu

Corporate News
ad-hoc notification

© 2025 All Rights Reserved by bioXXmed Ag

Disclaimer
Data Privacy
Legal information

Menu

Disclaimer
Data Privacy
Legal information

EN

+49 6151 951 58 12

Board of Directors: Dr Bruno Rosen
Butzbacher Weg 6
64289 Darmstadt
Germany

I allow my details from the contact form to be collected and processed in order to answer my inquiry. The data will be deleted after the processing of your request has been completed.
Note: You can revoke your consent at any time for the future by sending an e-mail to. Detailed information on the handling of user data can be found in our privacy policy.

+49 6221 6492488

kontakt@bioxxmed.ag

Board of Directors: Dr Bruno Rosen
Andreas Danner
Ziegelhäuser Landstraße 3
69120 Heidelberg
Germany